Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Khiron Life Sciences Corp. (V:KHRN)

Business Focus: Alternative Medicine

INK Edge Outlook

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for KHRN within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Dec 03, 2019 23:01 ET
Khiron Welcomes Legalization of Medical Cannabis in Brazil
Brazil represents the largest addressable market in Latin America with a population of 208 million and a potential USD $229 Million patient network for medical cannabis (New Frontier Data) Brazilian national health authority (ANVISA) approves the sale of medical cannabis products for sale by prescription and through pharmacies Khiron to participate in Brazil medical cannabis market through the Mercosur Regional Trading Bloc Regulations come into force 90 days after imminent posting on Federal Official Gazette TORONTO, Dec. 4, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Compan
Read full article
Nov 29, 2019 16:00 ET
Khiron Announces Chairman Transition and Appointment of Audit Committee Chair
TORONTO, Nov. 29, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, today announced that Sidney Himmel has resigned as Director and Chair of the Board to pursue other interests, effective immediately.
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
N/A
--
--
Price to Sales - TTM
13.84
9.22
8.49
Price to Book - most recent quarter
1.31
1.51
2.00
Price to Cash Flow per share - TTM
--
5.31
10.49
Price to Free Cash Flow per share - TTM
--
1.48
25.57
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Nov 15, 2019867,499152,088
Oct 31, 2019715,411172,892
Oct 15, 2019542,519223,176
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Khiron Life Sciences Corp, formerly Adent Capital Corp, is a Canada-based company engaged in alternative medicine sector. The Company is an integrated medical cannabis company with its core operations in Latin America. Khiron is active in the research area in medical cannabis industry. It develops and commercializes medical cannabis products mainly in Colombia.

See business summary

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).

Twitter

Search (past week) for $KHRN.CA KHRN.V